Ligand validation:2X21

PID: PERIDININ

PID is a Ligand Of Interest in 2X21 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2X21_PID_M_614	93%	7%	0.076	0.972	1.54	3.17	10	18	0	0	100%	1
2X21_PID_M_611	93%	5%	0.076	0.971	1.8	3.4	13	21	0	0	100%	0.9565
2X21_PID_M_613	87%	6%	0.095	0.967	1.61	3.51	10	21	1	0	100%	1
2X21_PID_M_612	68%	6%	0.104	0.915	1.61	3.3	9	21	2	0	100%	1
2X1Z_PID_M_614	99%	6%	0.057	0.984	1.47	3.58	5	26	0	0	100%	1
3IIS_PID_M_611	94%	12%	0.074	0.973	1.28	2.72	4	14	0	0	100%	0.8804
2X20_PID_M_614	92%	6%	0.086	0.976	1.43	3.64	7	16	0	0	100%	1
3IIU_PID_M_614	89%	11%	0.081	0.959	1.18	2.94	3	12	0	0	100%	1
8OV5_PID_N_624	99%	53%	0.048	0.986	1	0.82	2	2	2	0	100%	1
8OW6_PID_D_612	97%	39%	0.064	0.982	1.37	1.01	9	3	0	0	100%	1
1PPR_PID_N_621	95%	14%	0.078	0.98	1.77	2.12	9	15	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.